Healthcare & Medical Devices Global On demand · 24-48h

Global Dura (Spinal) Patch Market Strategic Research Report

Global Dura (Spinal) Patch Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Dura (Spinal) Patch Market
$8452025
6.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Absorbable, Non-absorbable

By Application: Public Hospital, Private Hospital

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Integra LifeSciences, B. Braun (Aesculap), Johnson & Johnson, Baxter, Regenity, Evergen, Gore, GUNZE, Tianxinfu Medical Appliance, Guanhao Biotech, Zhenghai Bio-Tech, Medprin Biotech, Balance Medical, Bonsci Technology, Biosis Healing Biological

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$845
Million USD
Forecast CAGR
6.3%
2025-2032
Forecast 2032
$1296
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Dura (Spinal) Patch market size is predicted to grow from US$ 845 million in 2025 to US$ 1,294 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Dura (spinal) patch refers to a sheet-like material product used for temporary or permanent repair of dura and/or dura defects.

Upstream inputs mainly include biological raw materials (such as purified collagen matrices, bovine pericardium, or porcine small-intestinal-submucosa-derived extracellular matrix), synthetic polymer materials (such as ePTFE and other medical polymers), and supporting materials/process inputs including sterilization media, packaging systems, and quality-control/biocompatibility testing. Downstream, the product is primarily used in cranial and spinal neurosurgery for dural defect repair/reconstruction (including tumor surgery, skull-base procedures, trauma-related repair, and other procedures involving dural opening), with the core clinical goal of restoring the dural barrier and helping reduce complications such as cerebrospinal fluid (CSF) leakage.

In 2025, global sales of Dura (Spinal) Patch reached approximately 2,127 K Pcs, with an average global market price of around US$ 406/Pcs. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 80% to 95%.

Large Market Potential:

Neurosurgery, one of the most complex medical disciplines, is a clinical surgical specialty that primarily uses surgery to treat diseases of the central nervous system (brain and spinal cord), peripheral nervous system, and autonomic nervous system. With the continuous improvement of living standards in China, the accelerated aging of the population, and factors such as accidental injuries, brain diseases primarily treated with surgery, such as brain tumors, craniocerebral trauma, cerebral hemorrhage, and functional neurological disorders, are also on the rise. Furthermore, with increasing awareness of diseases and the development of surgical instruments, treatment methods are changing. More and more conditions, such as epilepsy and pain, can now be effectively treated surgically. Overall, the field of neurosurgery has significant development potential. The market for high-value consumables used in neurosurgery is enormous.

High Degree of Domestication:

Compared to other high-value consumables, dural patches have a high degree of domestication, accounting for approximately 80% of the Chinese market share.

Increased policy support:

To reduce the burden of individual medical expenses and improve access to high-value medical consumables, the National Medical Insurance Administration (NMIA) has issued several new policies encouraging the expansion of reimbursement for these consumables, increasing the proportion of unified reimbursement, and achieving full coverage from urban residents' medical insurance to rural cooperative medical care. In response to these policies, local governments have continuously adjusted their medical insurance catalogs based on their respective fiscal strengths. These adjustments have led to a gradual decrease in out-of-pocket patient expenses and increased access to high-value medical consumables, driving continued growth in the dura mater patch market.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dura (Spinal) Patch market?

What factors are driving Dura (Spinal) Patch market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dura (Spinal) Patch market opportunities vary by end market size?

How does Dura (Spinal) Patch break out by Type, by Application?

This report presents a comprehensive overview of the global Dura (Spinal) Patch market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Absorbable
  • Non-absorbable

Segment by Material Composition

  • Biological Patch
  • Synthetic Patch

Segment by Fixation Method

  • Suturable
  • Onlay

Segment by Application

  • Public Hospital
  • Private Hospital

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Dura (Spinal) Patch market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Public Hospital, Private Hospital evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Dura (Spinal) Patch Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$845
2025
Forecast
$1296
2032
CAGR
6.3%
2025–2032
Regions
5
global
Key companies
Integra LifeSciencesB. Braun (Aesculap)Johnson & JohnsonBaxterRegenityEvergenGoreGUNZE
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
AbsorbableNon-absorbable
By Application
Public HospitalPrivate Hospital

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Absorbable
  • 3.1.3 Non-absorbable
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Public Hospital
  • 4.1.3 Private Hospital
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Integra LifeSciences
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 B. Braun (Aesculap)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Johnson & Johnson
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Baxter
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Regenity
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Evergen
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Gore
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 GUNZE
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Tianxinfu Medical Appliance
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Guanhao Biotech
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Zhenghai Bio-Tech
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Medprin Biotech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Balance Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Bonsci Technology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Biosis Healing Biological
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Dura (Spinal) Patch market size?
The global Dura (Spinal) Patch market is estimated at US$ 845 million in 2025 (base year) and is projected to reach US$ 1.29 billion by 2032.
What growth rate is expected for the Dura (Spinal) Patch market through 2032?
The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 845 million in 2025 to US$ 1.29 billion in 2032, roughly 1.5 times its base-year value.
How is Dura (Spinal) Patch defined?
Dura (spinal) patch refers to a sheet-like material product used for temporary or permanent repair of dura and/or dura defects.
What are the main segments of the Dura (Spinal) Patch market by type?
By type, the market is segmented into Absorbable and Non-absorbable.
Which applications drive demand in the Dura (Spinal) Patch market?
Key applications covered include Public Hospital and Private Hospital.
Who are the key players in the Dura (Spinal) Patch market?
Key players profiled include Integra LifeSciences, B. Braun (Aesculap), Johnson & Johnson, Baxter, Regenity, Evergen, Gore and GUNZE, among 15 companies covered in total.
Which regions and countries are covered for Dura (Spinal) Patch?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Dura (Spinal) Patch market?
These adjustments have led to a gradual decrease in out-of-pocket patient expenses and increased access to high-value medical consumables, driving continued growth in the dura mater patch market.
What challenges does the Dura (Spinal) Patch market face?
Downstream, the product is primarily used in cranial and spinal neurosurgery for dural defect repair/reconstruction (including tumor surgery, skull-base procedures, trauma-related repair, and other procedures involving dural opening), with the core clinical goal of restoring the dural barrier and helping reduce complications such as cerebrospinal fluid (CSF) leakage.
Who should buy the Dura (Spinal) Patch market report?
The report is intended for manufacturers and solution providers, distributors and end users in Public Hospital and Private Hospital, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Dura (Spinal) Patch market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.